Voduc D - Search Results

1

Supervised risk predictor of breast cancer based on intrinsic subtypes.

Parker JS, Mullins M, Cheang MC, Leung S, Voduc D, Vickery T, Davies S, Fauron C, He X, Hu Z, Quackenbush JF, Stijleman IJ, Palazzo J, Marron JS, Nobel AB, Mardis E, Nielsen TO, Ellis MJ, Perou CM, Bernard PS. Parker JS, et al. Among authors: voduc d. J Clin Oncol. 2009 Mar 10;27(8):1160-7. doi: 10.1200/JCO.2008.18.1370. Epub 2009 Feb 9. J Clin Oncol. 2009. PMID: 19204204 Free PMC article. Corrected and republished.

2

Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 cases.

Rajput AB, Turbin DA, Cheang MC, Voduc DK, Leung S, Gelmon KA, Gilks CB, Huntsman DG. Rajput AB, et al. Breast Cancer Res Treat. 2008 Jan;107(2):249-57. doi: 10.1007/s10549-007-9546-3. Epub 2007 Mar 13. Breast Cancer Res Treat. 2008. PMID: 17431762 Free PMC article.

3

GATA-3 expression in breast cancer has a strong association with estrogen receptor but lacks independent prognostic value.

Voduc D, Cheang M, Nielsen T. Voduc D, et al. Cancer Epidemiol Biomarkers Prev. 2008 Feb;17(2):365-73. doi: 10.1158/1055-9965.EPI-06-1090. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18268121

4

Tissue microarrays in clinical oncology.

Voduc D, Kenney C, Nielsen TO. Voduc D, et al. Semin Radiat Oncol. 2008 Apr;18(2):89-97. doi: 10.1016/j.semradonc.2007.10.006. Semin Radiat Oncol. 2008. PMID: 18314063 Free PMC article. Review.

5

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype.

Cheang MC, Voduc D, Bajdik C, Leung S, McKinney S, Chia SK, Perou CM, Nielsen TO. Cheang MC, et al. Among authors: voduc d. Clin Cancer Res. 2008 Mar 1;14(5):1368-76. doi: 10.1158/1078-0432.CCR-07-1658. Clin Cancer Res. 2008. PMID: 18316557

6

The combination of high cyclin E and Skp2 expression in breast cancer is associated with a poor prognosis and the basal phenotype.

Voduc D, Nielsen TO, Cheang MC, Foulkes WD. Voduc D, et al. Hum Pathol. 2008 Oct;39(10):1431-7. doi: 10.1016/j.humpath.2008.03.004. Epub 2008 Jul 11. Hum Pathol. 2008. PMID: 18620730

7

Basal and triple-negative breast cancers: impact on clinical decision-making and novel therapeutic options.

Voduc D, Nielsen TO. Voduc D, et al. Clin Breast Cancer. 2008 Dec;8 Suppl 4:S171-8. doi: 10.3816/CBC.2008.s.014. Clin Breast Cancer. 2008. PMID: 19158038 Review.

8

Ki67 index, HER2 status, and prognosis of patients with luminal B breast cancer.

Cheang MC, Chia SK, Voduc D, Gao D, Leung S, Snider J, Watson M, Davies S, Bernard PS, Parker JS, Perou CM, Ellis MJ, Nielsen TO. Cheang MC, et al. Among authors: voduc d. J Natl Cancer Inst. 2009 May 20;101(10):736-50. doi: 10.1093/jnci/djp082. Epub 2009 May 12. J Natl Cancer Inst. 2009. PMID: 19436038 Free PMC article.

9

HER-3 overexpression is prognostic of reduced breast cancer survival: a study of 4046 patients.

Chiu CG, Masoudi H, Leung S, Voduc DK, Gilks B, Huntsman DG, Wiseman SM. Chiu CG, et al. Ann Surg. 2010 Jun;251(6):1107-16. doi: 10.1097/SLA.0b013e3181dbb77e. Ann Surg. 2010. PMID: 20485140

10

Metastatic behavior of breast cancer subtypes.

Kennecke H, Yerushalmi R, Woods R, Cheang MC, Voduc D, Speers CH, Nielsen TO, Gelmon K. Kennecke H, et al. Among authors: voduc d. J Clin Oncol. 2010 Jul 10;28(20):3271-7. doi: 10.1200/JCO.2009.25.9820. Epub 2010 May 24. J Clin Oncol. 2010. PMID: 20498394

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

21 results

Search Page